Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt repayments
Ratios

HeartSciences (HSCSW) Accumulated Depreciation & Amortization (2022 - 2025)

Historic Accumulated Depreciation & Amortization for HeartSciences (HSCSW) over the last 4 years, with Q4 2025 value amounting to $551475.0.

  • HeartSciences' Accumulated Depreciation & Amortization rose 527.59% to $551475.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $551475.0, marking a year-over-year increase of 527.59%. This contributed to the annual value of $537358.0 for FY2025, which is 752.34% up from last year.
  • Latest data reveals that HeartSciences reported Accumulated Depreciation & Amortization of $551475.0 as of Q4 2025, which was up 527.59% from $544469.0 recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Accumulated Depreciation & Amortization ranged from a high of $551475.0 in Q4 2025 and a low of $444952.0 during Q2 2022
  • Over the past 4 years, HeartSciences' median Accumulated Depreciation & Amortization value was $490558.0 (recorded in 2024), while the average stood at $496424.9.
  • Within the past 5 years, the most significant YoY rise in HeartSciences' Accumulated Depreciation & Amortization was 800.86% (2025), while the steepest drop was 527.59% (2025).
  • Quarter analysis of 4 years shows HeartSciences' Accumulated Depreciation & Amortization stood at $458177.0 in 2022, then grew by 6.26% to $486841.0 in 2023, then rose by 7.6% to $523838.0 in 2024, then grew by 5.28% to $551475.0 in 2025.
  • Its Accumulated Depreciation & Amortization stands at $551475.0 for Q4 2025, versus $544469.0 for Q3 2025 and $537358.0 for Q2 2025.